AstraZeneca To Begin Fresh Global Trial Of Its Vaccine After Dosing Error l ABP Uncut
ABP News Bureau
Updated at:
01 Jan 1970 05:30 AM (IST)
Download ABP Live App and Watch All Latest Videos
View In App
One of the frontrunners in the Covid-19 vaccine, British-Swedish pharma company AstraZeneca has announced that they will begin an additional global trial to assess the efficacy of its Covid-19 vaccine. This comes after the companu acknowledged that there was an error in doses during its vaccine trials. Watch the video to know more.